{"id":"W2994953762","doi":"10.1016/j.jval.2019.09.776","title":"PCV51 COST-EFFECTIVENESS OF RIVAROXABAN IN THE TREATMENT OF PATIENTS WITH CHRONIC CAD OR PAD IN THE UK","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Rivaroxaban; Medicine; Stroke (engine); Myocardial infarction; Coronary artery disease; Cost effectiveness; Quality-adjusted life year; Internal medicine; Emergency medicine; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002943225,0.0005090907,0.001839801,0.001630047,0.0002400043,0.002522788,0.000553569,0.001750015,0.004936591],"category_scores_gemma":[0.0246924,0.0003815306,0.002764895,0.001989687,0.0005169159,0.0014144,0.001231204,0.002462655,0.0003236734],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005840545,"about_ca_system_score_gemma":0.002606926,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02762318,"about_ca_topic_score_gemma":0.0157791,"domain_scores_codex":[0.9936171,0.003856301,0.0008315613,0.0003617876,0.0008569839,0.0004763649],"domain_scores_gemma":[0.9922515,0.004041559,0.001763218,0.0001832296,0.0007326838,0.00102788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.180289,0.0009581741,0.1651829,0.01757218,0.01979985,0.002254901,0.0005665684,0.05738979,0.001444109,0.01064629,0.05082522,0.4930709],"study_design_scores_gemma":[0.05971868,0.0257865,0.7574093,0.01768121,0.01869075,0.005571677,0.001255395,0.05136828,0.001102152,0.005761681,0.05505412,0.0006002475],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7306661,0.2224641,0.0008396634,0.01709594,0.001639803,0.0003156415,0.01126751,0.00006750238,0.01564382],"genre_scores_gemma":[0.9799716,0.01489686,0.0002544426,0.0007302767,0.0002462158,0.0000947203,0.003046503,0.0000144704,0.0007448631],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02762318,"threshold_uncertainty_score":0.05492479,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3292431132372878,"score_gpt":0.4187084369361606,"score_spread":0.08946532369887272,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}